General
Preferred name
PEMOLINE
Synonyms
Lilly brand of pemoline ()
Hyton ()
Stimul ()
Nitan ()
Dantromin ()
Pemolin ()
Deltamin ()
NSC-25159 ()
Tradon ()
Stimulol ()
Ronyl ()
Phenylpseudohydantoin ()
Pioxol ()
Okodon ()
Tradone ()
Deltamine ()
Kethamed ()
Pondex ()
NSC-169499 ()
Volital ()
Centramin ()
Pheniminooxazolidinone ()
Phenylisohydantoin ()
Sigmadyn ()
Cylert ()
Phenoxazole ()
YH-1 ()
Azoxodone ()
LA-956 ()
Azoxodon ()
Azoksodon ()
Sistra ()
Hyton asa ()
Fenoxazol ()
P&D ID
PD002922
CAS
2152-34-3
101053-01-4
Tags
natural product
drug
available
Approved by
FDA
First approval
1975
Drug Status
illicit
investigational
approved
withdrawn
Max Phase
Phase 4
Drug indication
Stimulant (central)
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
14
Cayman Chemical Bioactives
14208
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
CHEMBL1177
ChEMBL Drugs
CHEMBL1177
DrugBank
DB01230
DrugBank Approved Drugs
DB01230
DrugCentral
2075
DrugCentral Approved Drugs
2075
DrugMatrix
LSP-MoA library (Laboratory of Systems Pharmacology)
CHEMBL1177
NIH Clinical Collections (NCC)
NPC Screening Collection
ReFrame library
Withdrawn 2.0
w95
External IDs
32
Properties
(calculated by RDKit )
Molecular Weight
176.06
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
2
Aromatic Ring Count
1
cLogP
0.6
TPSA
64.68
Fraction CSP3
0.11
Chiral centers
1.0
Largest ring
6.0
QED
0.68
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
Unknown molecular target
ATC
N06BA05
Toxicity type
hepatic
Source data